H2-Receptor Antagonists Market: Growth, Future Prospects & Competitive Analysis, 2018-2026

$ 4325

The global H2-receptor antagonists (H2RA) market is projected to grow at a higher CAGR within the forecast period from 2018 to 2026. H2-receptor antagonists play a very important role in preventing the secretion of gastric acid and treating duodenal ulcers, peptic ulcers, and esophageal ulcers. There is a vast range of H2RA products available in the market in the form of tablets, solution, and injectables and so on, which can be easily available through prescriptions or over-the-counter (OTC) channel.

Preventive Healthcare Technologies, Products And Services Market By Type (Early Detection And Screening Technologies, Vaccines, Chronic Disease Management Technologies, Advanced Technologies To Reduce Errors) - Growth, Future Prospects, And Competitive Analysis, 2017 - 2025

$ 4325

The government health departments worldwide are actively seeking to achieve the welfare of the people and society by primarily focusing on the extending life expectancy, quality of life, free distribution of medications and so on. Rising prevalence of chronic diseases, and the corresponding increasing drug discovery and development studies performed by major pharmaceutical manufacturers and research organizations are driving the preventive healthcare technologies, products and services market.

Prebiotics In Animal Feed Market By Product (Inulin, Mannan oligosaccharides (MOS), Galacto oligosaccharides (GOSs), Fructo Oligosaccharide (FOS), Others (lactulose, lactobionic acid, etc.)), By Livestock (Poultry, Cattle, Swine, Aquaculture, Others (equine, rabbits, etc.)) - Growth, Share, Opportunities & Competitive Analysis, 2016 - 2022

$ 4325

Prebiotics are the non- digestible functional ingredients that selectively stimulate the growth of favorable bacteria’s in the gut of the host. Prebiotics facilitate the immune system thereby improving animal health.The market for prebiotics in animal feed is growing on the back of rising meat consumption. Meat and its products is considered as one of the major source of proteins, vitamins and mineralswhich are essential for growth and development.

Prebiotics Market By Type (Mannan-Oligosaccharides, Galacto-Oligosaccharides, Fructo-Oligosaccharides, Isomalto-Oligosaccharides, Inulin, Polydextrose, Others), By Health Benefits (Gut Health, Cardiovascular Health, Bone Health, Immunity, Weight Management), By Source (Roots, Vegetables, Grains, Others), By Application (Food & Beverages, Dietary Supplements, Animal Feed) - Growth, Share, Opportunities & Competitive Analysis, 2018 – 2026

$ 4325

Prebiotics market projected to exhibit the CAGR of 10.8% during the forecast period from 2018 to 2026. Prebiotics are functional ingredients that stimulates the growth of favorable bacteria’s present in the gut to facilitate digestion system. Prebiotics also facilitate the immune system, mitigate the risk of cardiovascular disease, and helps in improving gut health, thereby improving overall health of the host.

Polycystic Ovarian Syndrome (PCOS) Therapeutics Market By Drug Type (Oral Contraceptive, Ovulation Inducing Agents, Facial Hair Growth Inhibitor, Insulin Sensitizing Agent) - Growth, Future Prospects & Competitive Analysis, 2017- 2025

$ 4325

Polycystic ovarian syndrome (PCOS) is one of the most common endocrine disorders among women of reproductive age. Polycystic ovarian syndrome (PCOS) therapeutics market is rapidly growing due to factors such as growing prevalence, changing lifestyle pattern, early diagnosis and significant unmet needs.

Pneumococcal Vaccines Market By Vaccine Type (Pneumococcal Conjugate Vaccine, Pneumococcal Polysaccharide Vaccine), By Product Type (10-Valent PCV, 13-valent PCV, 23-valent PPSV) - Growth, Future Prospects & Competitive Analysis, 2018 – 2026

$ 4325

The global pneumococcal vaccines market held US$ 7,108.7 Mn in 2017 and expected to grow at compound annual growth rate (CAGR) of 5.1% during the forecast period from 2018 to 2026. Pneumococcal diseases are one of the leading cause of serious illness globally resulting in high number of hospitalization every year.

Phospholipase Enzyme Market By Source (Microbial, Plant Animal), By Product (PLA1, PLA2, PLB, PLC, PLD), By Application (Food & Beverages, Biofuel, Personal Care, Nutraceuticals, Animal Feed, Others) - Growth, Share, Opportunities & Competitive Analysis, 2018 – 2026

$ 4325

Phospholipase enzyme market is projected to reach US$ 482.4 Mn by 2026 with 7.0% CAGR during the forecast period from 2018 to 2026. In 2017, North America held the largest value share in the global phospholipase enzyme market. Asia Pacific is projected to be the fastest growing region between 2018 and 2026.

Photodynamic Therapy Market By Product (Photosensitizer Drugs, Laser Devices), By Application (Ophthalmology, Oncology, Dermatology) - Growth, Future Prospects & Competitive Analysis, 2018 – 2026

$ 4325

The photodynamic therapy market is set to grow at an impressive rate with a compounded annual growth rate (CAGR) of 5.7% during the forecast period from 2018 to 2026. As per the statistics provided by World Health Organization (WHO), currently 2 to 3 million non-melanoma and 132,000 melanoma skin cancer occurs throughout the globe annually.

Plasma Fractionation Market By Product (Coagulation Factor Concentrates, Immunoglobulin, Albumin, Protease Inhibitors and Others), By Application (Neurology, Immunology, Hematology, Critical Care and Others) - Growth, Future Prospects & Competitive Analysis, 2018 – 2026

$ 4325

The plasma fractionation market is set to reach from US$ 18,099.5 Mn in 2017 to US$ 33,386.6 Mn by 2026 at a compound annual growth rate (CAGR) of 7.1% during the forecast period from 2018 to 2026. Plasma fractionation is utilized for achieving large quantities of purified protein from human plasma. Researchers have been focusing diligently in understanding the role and significance of plasma derived proteins in treating chronic ailments and autoimmune diseases. Increasing demand for biologics and increasing healthcare expenditure for drug development activities together drive the plasma fractionation market growth.

Pharmaceutical CDMO Services Market By Service Type (Drug Substance Development And Manufacturing, Specialized Services, Lab-based Services), By Product Type (Innovator Drugs, Generic Drugs, Label Change, Others) - Growth, Share, Opportunities & Competitive Analysis, 2018 – 2026

$ 4325

The Contract Development and Manufacturing Organization (CDMO) industry had begun decades ago as a niche business by offering specialty services and manufacturing capacities to pharmaceutical companies. The advent of CDMOs was mainly attributed to the failures of pharmaceutical companies due to challenged competencies and financial constraints.

Oral Thin Film Drugs Market By Product (Sublingual Film, Fully Dissolving Buccal Film), By Indication (Migraine, Schizophrenia, Alzheimer’s Disease, Nausea & Vomiting, Opioid Dependence Tests) - Growth, Share, Opportunities & Competitive Analysis, 2017 - 2025

$ 4325

Thin film drugs have been identified as the alternative approach to the conventional dosage forms. Oral thin films are thin, flexible films of drug delivery that dissolve in the oral mucosa resulting in the rapid onset of action and improved bioavailability for drugs. The oral thin film are mostly used for the geriatric, pediatric and bedridden patient who are unable to intake the solid form of the drug. Rising demand for efficient drug delivery route and its acceptability in the region would further drive the thin film drug manufacturing market in the future.

Orthopedic Soft Tissue Repair Market By Procedure (Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapse, Gluteal Tendon Repair, Cruciate Ligaments Repair, Hip Arthroscopy, Biceps Tenodesis ), By Therapeutic Site (Knee, Shoulder, Hip ) - Growth, Future Prospects & Competitive Analysis, 2017- 2025

$ 4325

Orthopedic soft tissue repair products are used for reinforcement of weak, damaged or ruptured soft tissue. The growth of this market is mainly contributed by factors such as easy availability of novel products, increasing incidence of sports-related injuries, significant growth in highly vulnerable geriatric population.

Genital Herpes Treatment Drugs Market By Drug Class (Acyclovir, Famciclovir and Valacyclovir) - Growth, Future Prospects & Competitive Analysis, 2018 - 2026

$ 4325

The genital herpes treatment drugs market will be featuring magnificent growth at a compounded annual growth rate (CAGR) of 4.9% during the forecast period from 2018 to 2026. According to the latest research citing’s published by World Health Organization (WHO), approximately two-thirds of the global population under 50 years of age is infected with herpes simplex virus type 1 (HSV-1).

Generic Oncology Drugs Market By Molecule Type (Small Molecule and Large Molecule) - Growth, Future Prospects & Competitive Analysis, 2018 - 2026

$ 4325

The generic oncology drugs market is set to reach from US$ 17,151.0 Mn in 2017 to US$ 29,222.5 Mn by 2026 representing undeviated growth at a compounded annual growth rate (CAGR) of 6.1% during the forecast period from 2018 to 2026. According to the statistics provided by World Health Organization (WHO) in 2018, 9.6 million people worldwide have been estimated to be dead due to cancer. It is considered as the second leading cause of death, researchers are of the opinion that approximately 30% cancer deaths can be prevented by avoiding risk factors such as alcohol consumption, tobacco smoking, early diagnosis etc.

Interventional Pulmonology Market By Procedure (Flexible Bronchoscopy, Rigid Bronchoscopy, Bronchoalveolar Lavage, Lung Biopsy, Bronchial Stent, Balloon Bronchoplasty, Pleuroscopy and Others) - Growth, Future Prospects & Competitive Analysis, 2018 – 2026

$ 4325

The interventional pulmonology market is set to reach from US$ 1,145.6 Mn in 2017 to US$ 1,747.0 Mn by 2026 highlighting unswerving growth at a compounded annual growth rate (CAGR) of 4.8% during the forecast period from 2018 to 2026. As per the statistics provided by World Health Organization (WHO), in 2018 approximately 2.09 million people died due to lung cancer. Tobacco smoking is the leading causes of formation of malignant tumours and neoplasms in the lungs. Interventional pulmonology is a relatively new field which has gained tremendous attraction in the last decade which employs sophisticated tools to perform diagnosis and treatment of various pulmonary disorders. Apart from pulmonologist cardiothoracic surgeons also routinely perform interventional pulmonology procedures.

Iron Supplements Market By Form (Tablet, Liquid, Capsules, Syrup), By Application (Additional Supplements, Sports Nutrition, Medicinal Supplements) - Growth, Share, Opportunities & Competitive Analysis, 2017 - 2025

$ 4325

This report titled “Iron Supplements Market - Growth, Future Prospects, and Competitive Analysis, 2017 – 2025” offers strategic insights into the trends in the global iron supplements market along with the market size and forecast for the duration 2015 to 2025. The said research study incorporates in-depth analysis of multiple market segments based on form, application and geographical distribution.

Kidney Cancer/Renal Cell Carcinoma (RCC) Drugs Market By Type (Afinitor (Everolimus), Avastin (Bevacizumab), Cabomety (Cabozantinib), Inlyta (Axitinib), Nexavar (Sorafenib), Proleukin (Aldesleukin), Torisel (Temsirolimus), Sutent (Sunitinib), Votrient (Pazopanib)) - Growth, Future Prospects, And Competitive Analysis, 2017 -2025

$ 4325

Kidney cancer is the most common cancer in the world around 63,990 new cases are estimated to be in 2017. Among the primary kidney cancer, renal parenchymal cancer is the most common estimating around 80-90% and it is the most complex to treat. The chances of developing cancer is about 1 in 63 in lifetime, with higher risk in men than women.

Krill Oil Market by Product Type (Liquid, Tablet), by Application (Fortified Food & Beverages, Animal Feed, Dietary Supplements, Pharmaceuticals, Others), by Distribution Channel (Supermarkets/Hypermarkets, Departmental Store, Pharmacy Store, Online Store, Others) - Growth, Future Prospects & Competitive Analysis, 2018 – 2026

$ 4325

Krill are small, up to 6 cm, shrimplike shellfish at the base of the ocean’s food chain. Including 85 species of krill, the total estimated biomass of between 400 Mn and 600 Mn tones in 2016-17. For claimed health benefits of krill oil, including the management and treatment of conditions, such as hyperlipidemia, inflammation, and arthritis, there has been a noticeable increase in research and promotion of krill oil in recent years.

Opioid Drugs Market By Drug Type (Opioid Agonist (Morphine, Methadone, Codeine, Oxycodone, Meperidine, Fentanyl and Other Agonist), Opioid Antagonist (Naloxone, Naltrexone and Other Antagonist), By Application Type (Pain Management, Cough Suppressant, Diarrhea and Anesthesia)) - Growth, Future Prospects and Competitive Analysis, 2017 - 2025

$ 4325

Opioid is a drug class including a broad range of drugs such as morphine, oxycodone, fentanyl, hydrocodone and others with widened applications in pain management. Opioid drugs produce effective results by interacting with opioid receptors present on nerve cells. Globally, millions of people have been suffering from acute or chronic pain, thus having a huge impact on domestic healthcare expenditure and supporting the growth opportunity of opioid drugs market.

Fragment-based Drug Discovery Market By Service Type (Fragment Screening Technique, Fragment Optimization Technique), By End-User (Biopharmaceutical Companies, Contract Research Organization, Academic And Research Institutions) - Growth, Future Prospects & Competitive Analysis, 2018 – 2026

$ 4325

The global fragment-based drug discovery (FBDD) market held US$ 503.4 Mn in 2017 and expected to grow at compound annual growth rate (CAGR) of 11.8% during the forecast period from 2018 to 2026. Fragment-based drug discovery has emerged as a significant substitute to high throughput screening (HTS) in last two decades for the identification of lead compounds for drug discovery.

Pharmaceutical

The global pharmaceuticals market has been consistent of large companies based in US and Europe.  The pharma market is a challenging one and is constantly evolving to meeting the healthcare needs of a growing population. While generic drugs have dominated the market in developing countries the demand for the latest drug discoveries and better healthcare is increasing demand in these countries. The pharmaceutical industry has seen high level of mergers and acquisition which are helping it grow in a rationalized fashion.

Our reports help identify key industry statistics and trends. Brisk Insights focuses on important performance geographies and competitive analysis.